Advertisement

The effect of platelet-rich plasma injection on post-internal urethrotomy stricture recurrence

  • Mehran RezaeiEmail author
  • Rozhin Badiei
  • Ronak Badiei
Original Article

Abstract

Purpose

Local injection of platelet-rich plasma (PRP) is postulated to work by delivering growth factors and cytokines that recruit healer cells and enhance recovery process at the injection site. As new scar formation leads to stricture recurrence after internal urethrotomy, we proposed to improve post-internal urethrotomy stricture recurrence rate by injecting local submucosal PRP at the time of urethrotomy.

Methods

From July 2015 to June 2018, 87 male patients with symptomatic bulbar urethral stricture (diagnosed by retrograde urethrography) randomized into two groups of internal urethrotomy and submucosal normal saline injection (control group, 43 patients), and internal urethrotomy with submucosal autologous platelet-rich plasma injection (PRP injection group, 44 patients). According to the endpoint, which happened sooner, each patient was followed at 3-month intervals for 2 years after internal urethrotomy or until urethral stricture recurrence.

Results

Twelve-month recurrence rates were 26.82 and 9.09% in the control and the PRP injection groups, respectively (p 0.032). After 2 years of follow-up, stricture recurrence was identified in 18 (43.90%) and 9 (21.95%) patients in the control and the PRP injection groups, respectively (p 0.34).

Conclusion

In our study, submucosal PRP injection at the site of internal urethrotomy decreased the rate of stricture recurrence a year after the intervention. This protective effect lasted for 24 months, at least. Submucosal PRP injection at the time of internal urethrotomy also decreased the length of stricture in case of recurrence.

Keywords

Urethral stricture Internal urethrotomy Platelet-rich plasma 

Notes

Author contributions

MR: protocol/project development, data analysis, manuscript writing/editing. RB: protocol/project development, data collection or management. RB: data collection or management, data analysis.

Compliances with ethical standards

Conflict of interest

The authors whose names are listed certify that they have no affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest in the subject matter or materials discussed in this manuscript.

Research involving human participants and/or animals

The protocol of this research was approved by the research ethics committee of Shiraz University of Medical Sciences, Shiraz, Iran on April 7, 2015. All therapeutic and diagnostic interventions performed in this study were in accordance with the ethical standards of the institutional (Shiraz University of Medical Sciences) and national (Iran) research committee, and with the 1964 Helsinki Declaration of the World Medical Association and its later amendments. Written informed consent was obtained from all participants before entering the study.

Data sharing statement

Data are available for bonafide researchers who request it from the authors.

References

  1. 1.
    Sievert KD, Selent-Stier C, Wiedemann J, Greiner TO, Amend B, Stenzl A, Feil G, Seibold J (2012) Introducing a large animal model to create urethral stricture similar to human stricture disease: a comparative experimental microscopic study. J Urol 187(3):1101–1109.  https://doi.org/10.1016/j.juro.2011.10.132 CrossRefPubMedGoogle Scholar
  2. 2.
    Santucci RA, Joyce GF, Wise M (2007) Male urethral stricture disease. J Urol 177(5):1667–1674.  https://doi.org/10.1016/j.juro.2007.01.041 CrossRefPubMedGoogle Scholar
  3. 3.
    Tritschler S, Roosen A, Fullhase C, Stief CG, Rubben H (2013) Urethral stricture: etiology, investigation and treatments. Dtsch Arztebl Int 110(13):220–226.  https://doi.org/10.3238/arztebl.2013.0220 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Albers P, Fichtner J, Bruhl P, Muller SC (1996) Long-term results of internal urethrotomy. J Urol 156(5):1611–1614CrossRefGoogle Scholar
  5. 5.
    Pansadoro V, Emiliozzi P (1996) Internal urethrotomy in the management of anterior urethral strictures: long-term followup. J Urol 156(1):73–75CrossRefGoogle Scholar
  6. 6.
    Steenkamp JW, Heyns CF, de Kock ML (1997) Internal urethrotomy versus dilation as treatment for male urethral strictures: a prospective, randomized comparison. J Urol 157(1):98–101CrossRefGoogle Scholar
  7. 7.
    Wallace BJ, Cooper TP, Tremann JA, Ansell JS (1978) Results of large-caliber internal urethrotomy. Urology 11(4):366–368CrossRefGoogle Scholar
  8. 8.
    Sampson S, Gerhardt M, Mandelbaum B (2008) Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 1(3):165–174.  https://doi.org/10.1007/s12178-008-9032-5 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Gosens T, Peerbooms JC, van Laar W, den Oudsten BL (2011) Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med 39(6):1200–1208.  https://doi.org/10.1177/0363546510397173 CrossRefPubMedGoogle Scholar
  10. 10.
    Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA (2009) Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg 17(10):602–608CrossRefGoogle Scholar
  11. 11.
    Mishra A, Pavelko T (2006) Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 34(11):1774–1778.  https://doi.org/10.1177/0363546506288850 CrossRefPubMedGoogle Scholar
  12. 12.
    Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T (2010) Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med 38(2):255–262.  https://doi.org/10.1177/0363546509355445 CrossRefPubMedGoogle Scholar
  13. 13.
    Sampson S, Gerhardt M, Mandelbaum B (2008) Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 1(3–4):165–174.  https://doi.org/10.1007/s12178-008-9032-5 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Dragoo JL, Wasterlain AS, Braun HJ, Nead KT (2014) Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med 42(3):610–618.  https://doi.org/10.1177/0363546513518416 CrossRefPubMedGoogle Scholar
  15. 15.
    Tavukcu H, AytaÇ O, Atug F, Alev B, Cevik O, Yarat A, Cetinel S, Sener G, Kulaksizoglu H (2017) Mp94-01 protective effect of platelet-rich plasma on urethral stricture model of male rats. J Urol 197(4):e1245.  https://doi.org/10.1016/j.juro.2017.02.2904 CrossRefGoogle Scholar
  16. 16.
    Amable PR, Carias RBV, Teixeira MVT, da Cruz Pacheco I, Corrêa do Amaral RJF, Granjeiro JM, Borojevic R (2013) Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 4(3):67–67.  https://doi.org/10.1186/scrt218 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Gosain A, DiPietro LA (2004) Aging and wound healing. World J Surg 28(3):321–326.  https://doi.org/10.1007/s00268-003-7397-6 CrossRefPubMedGoogle Scholar
  18. 18.
    Broughton G 2nd, Janis JE, Attinger CE (2006) The basic science of wound healing. Plast Reconstr Surg 117(7 Suppl):12s–34s.  https://doi.org/10.1097/01.prs.0000225430.42531.c2 CrossRefPubMedGoogle Scholar
  19. 19.
    Campos AC, Groth AK, Branco AB (2008) Assessment and nutritional aspects of wound healing. Curr Opin Clin Nutr Metab Care 11(3):281–288.  https://doi.org/10.1097/MCO.0b013e3282fbd35a CrossRefPubMedGoogle Scholar
  20. 20.
    Guo S, Dipietro LA (2010) Factors affecting wound healing. J Dent Res 89(3):219–229.  https://doi.org/10.1177/0022034509359125 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Amable PR, Carias RBV, Teixeira MVT, da Cruz Pacheco Í, Corrêa do Amaral RJF, Granjeiro JM, Borojevic R (2013) Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 4(3):67.  https://doi.org/10.1186/scrt218 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Amable PR, Carias RBV, Teixeira MVT, da Cruz Pacheco Í, Corrêa do Amaral RJF, Granjeiro JM, Borojevic R (2013) Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 4(3):67–67.  https://doi.org/10.1186/scrt218 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Dawood AS, Salem HA (2018) Current clinical applications of platelet-rich plasma in various gynecological disorders: an appraisal of theory and practice. Clin Exp Reprod Med 45(2):67–74.  https://doi.org/10.5653/cerm.2018.45.2.67 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Albanese A, Licata ME, Polizzi B, Campisi G (2013) Platelet-rich plasma (PRP) in dental and oral surgery: from the wound healing to bone regeneration. Immun Ageing I A 10:23–23.  https://doi.org/10.1186/1742-4933-10-23 CrossRefPubMedGoogle Scholar
  25. 25.
    Gkini MA, Kouskoukis AE, Tripsianis G, Rigopoulos D, Kouskoukis K (2014) Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg 7(4):213–219.  https://doi.org/10.4103/0974-2077.150743 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Scarcia M, Maselli FP, Cardo G, Ludovico GM (2016) The use of autologous platelet rich plasma gel in bulbar and penile buccal mucosa urethroplasty: preliminary report of our first series. Arch Ital Urol Androl 88(4):274–278.  https://doi.org/10.4081/aiua.2016.4.274 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Ghaem HospitalShiraz University of Medical SciencesFirouzabadIran
  2. 2.Shiraz University of Medical SciencesShirazIran
  3. 3.Fasa University of Medical SciencesFasaIran

Personalised recommendations